Please use this identifier to cite or link to this item:
Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the PAVES Study
Authors: Tamás Pintera
Zandra Klippel
Alvydas Cesas
Adina Croitoru
Jochen Decaestecker
Peter Gibbs
Yevhen Hotko
Jacek Jassem
Galina Kurteva
Jan Novotny
Seamus O’Reilly
Tomas Salek
Maureen Reiner
Phuong Khanh Morrow
Mi Rim Choi
Sadie Whittaker
Charles Blanke
Keywords: Pegfilgrastim, colorectal cancer, febrile neutropenia, overall survival
Issue Date: 2013
Type: Text
Publication type: Стаття
Appears in Collections:Наукові публікації кафедри радіології та онкології

Files in This Item:
File Description SizeFormat 
Abstract.PDF277.5 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.